Greenford, United Kingdom

Stuart Holman

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Inc.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stuart Holman. Retrieved from https://idiyas.com/inventor/stuart-holman-ccdv3o15

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Stuart Holman

Introduction

Stuart Holman, an accomplished inventor based in Greenford, GB, has made significant contributions to the field of chemistry. His innovative spirit is exemplified by his patent for 1-azatricyclo[7.2.0.0.sup.3,8]undec-2-ene-2-carboxylates, showcasing his dedication to advancing scientific knowledge and application.

Latest Patents

Stuart Holman holds a patent for 1-azatricyclo[7.2.0.0.sup.3,8]undec-2-ene-2-carboxylates. This invention is a testament to his ability to create novel compounds that could have valuable applications in various industries, particularly in pharmaceuticals.

Career Highlights

Holman has established himself at Glaxo S.p.A., a renowned company in the pharmaceutical sector. His work there emphasizes the intersection of research, development, and innovation, driven by a mission to enhance health outcomes through advanced scientific discoveries.

Collaborations

Throughout his career, Holman has collaborated with notable colleagues, including Roberto Carlesso and Alcide Perboni. These partnerships reflect a collaborative approach to research and development, enriching the inventiveness and effectiveness of their projects.

Conclusion

Stuart Holman epitomizes the role of the modern inventor, combining creativity with scientific rigor. His patent and work at Glaxo S.p.A. highlight the importance of innovations in addressing complex challenges in science and health. As he continues on his path, Holman's contributions are likely to impact the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…